Cointime

Odyssey Therapeutics

company

About

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

  • 101 - 250

Highlights

Total Funding Amount
$168M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series B
Last Funding Money Raised
$168M
Industries
Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 2021
Number Of Employee
101 - 250
Operating Status
Active

Odyssey Therapeutics is a biotechnology company pioneering the efficient development of next-generation immunomodulators and oncology medicines. Odyssey is making a transformational impact on the field of drug discovery and is accelerating the path to clinical development to drive the creation of more effective precision medicines. The company's integrated drug-hunting engine is designed to accelerate drug discovery by unlocking targets with great potential and minimizing attrition.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$168M
Odyssey Therapeutics has raised a total of $168M in funding over 2 rounds. Their latest funding was raised on Oct 13, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 13, 2022 Series B $168M 1 General Catalyst — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Odyssey Therapeutics is funded by 1 investors. General Catalyst are the most recent investors.
Investor Name Lead Investor Funding Round
General Catalyst Yes Series B
Cointime
Chủ Đề
Công Ty